- Home
- LNSR
LNSR
LENSAR Inc.
as 07-26-2024 4:00pm EST
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | ORLANDO |
| Market Cap: | 56.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 18.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.58 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $5.60 | Next Earning Date: | 08-07-2024 |
| Revenue: | $44,500,000 | Revenue Growth: | 29.85% |
| Revenue Growth (this year): | 22.89% | Revenue Growth (next year): | 22.74% |
Stock Insider Trading Activity of LENSAR Inc. (LNSR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Winer Gary M | LNSR | Director | Nov 22 '23 | Buy | $2.10 | 300 | $630.00 | 53,345 | SEC Form 4 |
Latest LENSAR Inc. News
LNSR Breaking Stock News: Dive into LNSR Ticker-Specific Updates for Smart Investing
Business Wire
24 days ago
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
2 months ago
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire
2 months ago
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
Insider Monkey
2 months ago
LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript
Simply Wall St.
2 months ago
LENSAR, Inc. (NASDAQ:LNSR) Just Reported, And Analysts Assigned A US$8.00 Price Target
Simply Wall St.
3 months ago
LENSAR First Quarter 2024 Earnings: EPS Beats Expectations
Business Wire
3 months ago
LENSAR Reports First Quarter 2024 Results and Provides Business Update
Business Wire
3 months ago
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
Compare LNSR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LNSR LENSAR Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.